Abstract: The present disclosure relates to novel and advantageous treatments for foliar disease. Particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions for controlling, treating, or preventing for foliar disease in trees and shrubs. More particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions comprising flutriafol for controlling, treating, or preventing for foliar disease in trees and shrubs wherein the treatment may be done via soil application.

Abstract: The present disclosure relates to compositions and methods of regulating growth of a live plant to slow the growth of the live plant. In one embodiment, the composition consists essentially of a first component comprising a gibberellin inhibiting plant growth regulating agent and a second component comprising at least one of a short-chained monocarboxylic acid having from five to eight carbon atoms, a derivative thereof, a salt thereof, and a mixture thereof. The second component increases the efficacy of the first component such that a plant treated with the composition has slower growth than a plant treated only with the first component. In some embodiments, the second component is hexanoic acid, and the first component is paclobutrazol.

Abstract: The present disclosure relates to novel and advantageous treatments for foliar disease. Particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions for controlling, treating, or preventing for foliar disease in trees and shrubs. More particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions comprising flutriafol for controlling, treating, or preventing for foliar disease in trees and shrubs wherein the treatment may be done via soil application.

Abstract: The present disclosure relates to novel and advantageous treatments for foliar disease. Particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions for controlling, treating, or preventing for foliar disease in trees and shrubs. More particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions comprising flutriafol for controlling, treating, or preventing for foliar disease in trees and shrubs wherein the treatment may be done via soil application.

Abstract: The present disclosure relates to novel and advantageous treatments for foliar disease. Particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions for controlling, treating, or preventing for foliar disease in trees and shrubs. More particularly, the present disclosure relates to novel and advantageous treatment compositions and methods for applying such treatment compositions comprising flutriafol for controlling, treating, or preventing for foliar disease in trees and shrubs wherein the treatment may be done via soil application.

Abstract: The present disclosure relates to compositions and methods of regulating growth of a live plant to slow the growth of the live plant. In one embodiment, the composition consists essentially of a first component comprising a gibberellin inhibiting plant growth regulating agent and a second component comprising at least one of a short-chained monocarboxylic acid having from five to eight carbon atoms, a derivative thereof, a salt thereof, and a mixture thereof. The second component increases the efficacy of the first component such that a plant treated with the composition has slower growth than a plant treated only with the first component. In some embodiments, the second component is hexanoic acid, and the first component is paclobutrazol.